2seventy Bio Stock Probability of Future Stock Price Finishing Under 0.28

TSVT Stock  USD 3.65  0.13  3.44%   
2Seventy Bio's future price is the expected price of 2Seventy Bio instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of 2Seventy Bio performance during a given time horizon utilizing its historical volatility. Check out 2Seventy Bio Backtesting, 2Seventy Bio Valuation, 2Seventy Bio Correlation, 2Seventy Bio Hype Analysis, 2Seventy Bio Volatility, 2Seventy Bio History as well as 2Seventy Bio Performance.
For more information on how to buy 2Seventy Stock please use our How to Invest in 2Seventy Bio guide.
  
Price Earnings To Growth Ratio is likely to gain to 0.03 in 2024, whereas Price To Sales Ratio is likely to drop 1.99 in 2024. Please specify 2Seventy Bio's target price for which you would like 2Seventy Bio odds to be computed.

2Seventy Bio Target Price Odds to finish below 0.28

The tendency of 2Seventy Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to drop to $ 0.28  or more in 90 days
 3.65 90 days 0.28 
near 1
Based on a normal probability distribution, the odds of 2Seventy Bio to drop to $ 0.28  or more in 90 days from now is near 1 (This 2Seventy Bio probability density function shows the probability of 2Seventy Stock to fall within a particular range of prices over 90 days) . Probability of 2Seventy Bio price to stay between $ 0.28  and its current price of $3.65 at the end of the 90-day period is nearly 4.71 .
Given the investment horizon of 90 days the stock has the beta coefficient of 2.96 . This usually implies as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, 2Seventy Bio will likely underperform. Additionally 2Seventy Bio has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial.
   2Seventy Bio Price Density   
       Price  

Predictive Modules for 2Seventy Bio

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as 2Seventy Bio. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of 2Seventy Bio's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.193.787.97
Details
Intrinsic
Valuation
LowRealHigh
2.716.9011.09
Details
Naive
Forecast
LowNextHigh
0.284.488.67
Details
5 Analysts
Consensus
LowTargetHigh
15.0216.5018.32
Details

2Seventy Bio Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. 2Seventy Bio is not an exception. The market had few large corrections towards the 2Seventy Bio's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold 2Seventy Bio, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of 2Seventy Bio within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
-0.61
β
Beta against Dow Jones2.96
σ
Overall volatility
0.52
Ir
Information ratio -0.1

2Seventy Bio Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of 2Seventy Bio for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for 2Seventy Bio can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
2Seventy Bio generated a negative expected return over the last 90 days
2Seventy Bio has high historical volatility and very poor performance
2Seventy Bio has a very high chance of going through financial distress in the upcoming years
The company reported the previous year's revenue of 100.39 M. Net Loss for the year was (217.57 M) with loss before overhead, payroll, taxes, and interest of (183.46 M).
2Seventy Bio currently holds about 357.93 M in cash with (166.86 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 9.45, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Over 91.0% of the company shares are owned by institutional investors
Latest headline from news.google.com: 2seventy bio, Inc. Reports Q3 Loss, Lags Revenue Estimates - MSN

2Seventy Bio Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of 2Seventy Stock often depends not only on the future outlook of the current and potential 2Seventy Bio's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. 2Seventy Bio's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding49.3 M
Cash And Short Term Investments217 M

2Seventy Bio Technical Analysis

2Seventy Bio's future price can be derived by breaking down and analyzing its technical indicators over time. 2Seventy Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of 2Seventy Bio. In general, you should focus on analyzing 2Seventy Stock price patterns and their correlations with different microeconomic environments and drivers.

2Seventy Bio Predictive Forecast Models

2Seventy Bio's time-series forecasting models is one of many 2Seventy Bio's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary 2Seventy Bio's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about 2Seventy Bio

Checking the ongoing alerts about 2Seventy Bio for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for 2Seventy Bio help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
2Seventy Bio generated a negative expected return over the last 90 days
2Seventy Bio has high historical volatility and very poor performance
2Seventy Bio has a very high chance of going through financial distress in the upcoming years
The company reported the previous year's revenue of 100.39 M. Net Loss for the year was (217.57 M) with loss before overhead, payroll, taxes, and interest of (183.46 M).
2Seventy Bio currently holds about 357.93 M in cash with (166.86 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 9.45, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Over 91.0% of the company shares are owned by institutional investors
Latest headline from news.google.com: 2seventy bio, Inc. Reports Q3 Loss, Lags Revenue Estimates - MSN

Additional Tools for 2Seventy Stock Analysis

When running 2Seventy Bio's price analysis, check to measure 2Seventy Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy 2Seventy Bio is operating at the current time. Most of 2Seventy Bio's value examination focuses on studying past and present price action to predict the probability of 2Seventy Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move 2Seventy Bio's price. Additionally, you may evaluate how the addition of 2Seventy Bio to your portfolios can decrease your overall portfolio volatility.